---
title: "This Interface Analyst Begins Coverage On A Bullish Note; Here Are Top 5 Initiations For Tuesday"
type: "News"
locale: "en"
url: "https://longbridge.com/en/news/286923370.md"
description: "Top Wall Street analysts have initiated coverage on several companies with varying ratings. Oklo Inc (OKLO) received a Peer Perform rating, X-Energy Inc (XE) an Overweight rating with a $41 price target, Mirum Pharmaceuticals Inc (MIRM) an Outperform rating with a $145 target, Interface Inc (TILE) a Buy rating with a $36 target, and Tyra Biosciences Inc (TYRA) a Peer Perform rating."
datetime: "2026-05-19T13:25:44.000Z"
locales:
  - [zh-CN](https://longbridge.com/zh-CN/news/286923370.md)
  - [en](https://longbridge.com/en/news/286923370.md)
  - [zh-HK](https://longbridge.com/zh-HK/news/286923370.md)
---

# This Interface Analyst Begins Coverage On A Bullish Note; Here Are Top 5 Initiations For Tuesday

Top Wall Street analysts changed their outlook on these top names. For a complete view of all analyst rating changes, including upgrades, downgrades and initiations, please see our analyst ratings page.

-   Wolfe Research analyst Steve Fleishman initiated coverage on **Oklo Inc** (NYSE:OKLO) with a Peer Perform rating. Oklo shares closed at $58.56 on Monday. See how other analysts view this stock.
-   Morgan Stanley analyst David Arcaro initiated coverage on **X-Energy Inc** (NASDAQ:XE) with an Overweight rating and announced a price target of $41. X-Energy shares closed at $25.60 on Monday. See how other analysts view this stock.
-   Wolfe Research analyst Kalpit Patel initiated coverage on **Mirum Pharmaceuticals Inc** (NASDAQ:MIRM) with an Outperform rating and announced a price target of $145. Mirum Pharmaceuticals shares closed at $95.49 on Monday. See how other analysts view this stock.
-   Benchmark analyst Reuben Garner initiated coverage on **Interface Inc** (NASDAQ:TILE) with a Buy rating and announced a price target of $36. Interface shares closed at $28.52 on Monday. See how other analysts view this stock.
-   Wolfe Research analyst Kalpit Patel initiated coverage on **Tyra Biosciences Inc** (NASDAQ:TYRA) with a Peer Perform rating. Tyra Biosciences shares closed at $35.66 on Friday. See how other analysts view this stock.

Considering buying TILE stock? Here’s what analysts think:

_Photo via Shutterstock_

### Related Stocks

- [TILE.US](https://longbridge.com/en/quote/TILE.US.md)
- [MIRM.US](https://longbridge.com/en/quote/MIRM.US.md)
- [XE.US](https://longbridge.com/en/quote/XE.US.md)
- [OKLO.US](https://longbridge.com/en/quote/OKLO.US.md)
- [TYRA.US](https://longbridge.com/en/quote/TYRA.US.md)

## Related News & Research

- [X-Energy is in a post-IPO slump. Why analysts say the nuclear stock can surge](https://longbridge.com/en/news/286929875.md)
- [Should Interface’s Upgraded 2026 Outlook and Open Air Expansion Require Action From TILE Investors?](https://longbridge.com/en/news/286843203.md)
- [Tyra Biosciences (NASDAQ:TYRA) Issues Quarterly Earnings Results](https://longbridge.com/en/news/286329899.md)
- [Interface declares $0.03 quarterly dividend per share](https://longbridge.com/en/news/286959791.md)
- [Oklo Earnings Are Imminent; These Most Accurate Analysts Revise Forecasts Ahead Of Earnings Call](https://longbridge.com/en/news/286104154.md)